Prosecution Insights
Last updated: October 02, 2026
Application No. 18/677,969

PERACETIC ACID STABILIZED COMPOSITIONS WITH STABLE LINING

Final Rejection §103
Filed
May 30, 2024
Priority
Sep 27, 2018 — provisional 62/737,475 +2 more
Examiner
MIGGINS, MICHAEL C
Art Unit
1615
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Medivators Inc.
OA Round
2 (Final)
81%
Grant Probability
Favorable
3-4
OA Rounds
1m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 81% — above average
81%
Career Allowance Rate
834 granted / 1032 resolved
+20.8% vs TC avg
Strong +17% interview lift
Without
With
+16.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
53 currently pending
Career history
1073
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
44.5%
+4.5% vs TC avg
§102
23.2%
-16.8% vs TC avg
§112
14.0%
-26.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1032 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . REJECTIONS WITHDRAWN All previous rejections have been withdrawn. REJECTIONS REPEATED There are no rejections repeated. NEW REJECTIONS Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-6 and 8 is/are rejected under 35 U.S.C. 103 as being unpatentable over Gu et al. (US 2016/0087250, cited by applicant) in view of Zakikhani et al. (US 5,980,776). Claim 4 recites an extrusion step which is a method limitation in a product claim and has been given little to no patentable weight since the method by which a product is made is not germane to the patentability of a product in a product claim (MPEP 2113). Gu discloses a container comprising: a container wall having an interior surface and an exterior surface, the container wall defining an interstitial space, wherein the container is sealable, wherein the container material that forms the container wall comprises a polymeric resin functionalized with phosphonic acid or 1-hydroxyethylidene-1,1,-diphosphonic acid associated with the interior surface of the container (paragraphs [0009], [0017-0018], [0028], [0031-0034]). Gu does not disclose wherein the polymeric resin functionalized with the phosphonic acid is a vinylidene diphosphonic acid or a copolymer of vinylidene diphosphonic acid, wherein the polymeric resin functionalized with the phosphonic acid is crosslinked. Zakikhani discloses wherein the polymeric resin functionalized with the phosphonic acid is a vinylidene diphosphonic acid or a copolymer of vinylidene diphosphonic acid, wherein the polymeric resin functionalized with the phosphonic acid is crosslinked (column 2, lines 1-17) in order to provide improved adhesion (column 1, lines 8-15). Therefore it would have been obvious to one of ordinary skill in the art at the time applicant’s invention was made to have provided wherein the polymeric resin functionalized with the phosphonic acid is a vinylidene diphosphonic acid or a copolymer of vinylidene diphosphonic acid, wherein the polymeric resin functionalized with the phosphonic acid is crosslinked in Gu in order to provide improved adhesion as taught or suggested by Zakikhani. Gu also discloses wherein the polymeric resin functionalized with the phosphonic acid is coated onto the interior surface of the container, wherein the polymeric resin functionalized with the phosphonic acid is embedded into the interior surface of the container, herein the container material is a polypropylene, a polyethylene, a polypropylene and polyethylene copolymer or a polyethylene and polypropylene blend, further comprising an outer coating or layer applied to the exterior portion of the container (paragraphs [0009], [0017-0018], [0028], [0031-0034]). ANSWERS TO APPLICANT’S ARGUMENTS Applicant’s arguments of 7/22/26 have been carefully considered but are moot in view of the new grounds for rejection set forth above. With regards to Gu, applicant has argued that the phosphate containing of Gu does not form the container wall itself. However, Gu discloses the copolymer layer (4 from Fig. 2) which forms at least part of the container wall and the copolymer layer containers vinyl phosphonic acid copolymer (paragraphs [0032-0033]). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL C MIGGINS whose telephone number is (571)272-1494. The examiner can normally be reached Monday-Friday, 1-9 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Aaron Austin can be reached at 571-272-8935. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL C MIGGINS/Primary Examiner, Art Unit 1782 MCM August 23, 2026
Read full office action

Prosecution Timeline

May 30, 2024
Application Filed
Jul 21, 2026
Non-Final Rejection mailed — §103
Jul 22, 2026
Response Filed
Aug 26, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746743
Multilayer Biodegradable Tube Laminate with Paper Layer and Protective Coating Arranged Thereon, Tube Body, and Tube
2y 8m to grant Granted Sep 29, 2026
Patent 12741452
HEAT AND SHOCK RESISTANT TRANSPARENT MEMBRANE
3y 6m to grant Granted Sep 22, 2026
Patent 12721931
FLEXIBLE TUBE FOR ENDOSCOPE, ENDOSCOPIC MEDICAL DEVICE, AND METHODS FOR PRODUCING THE SAME
3y 8m to grant Granted Sep 01, 2026
Patent 12722364
Article
3y 3m to grant Granted Sep 01, 2026
Patent 12725763
CERAMIC SINTERED BODY FOR SEMICONDUCTOR PRODUCTION EQUIPMENT AND MANUFACTURING METHOD THEREOF
2y 8m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
81%
Grant Probability
97%
With Interview (+16.6%)
2y 5m (~1m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1032 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month